Monica Notarbartolo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Monica Notarbartolo has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Alessandra Montalbano
1 shared publication- Fanny Pojero
Laboratory of Immunopathology and Immunosenescence, Department of Biomedicine, Neurosciences and Advanced Technologies, University of Palermo, 90133 Palermo, Italy
1 shared publication - Giuseppe Montalto
Department of Health Promotion Sciences Maternal and Infantile Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, 90127 Palermo, Italy
1 shared publication Luisa Dusonchet
Dipartimento di Scienze Farmacologiche, Università di Palermo, 90127 Palermo, Italy
1 shared publication- Lydia Giannitrapani
Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, 90127 Palermo, Italy
1 shared publication - Maria Meli
Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy
1 shared publication
Latest Publications
- 1 October 2019
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 180, 465-485
Targeting multiple myeloma with natural polyphenols
- 1 October 2019
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 180, 465-485
Targeting multiple myeloma with natural polyphenols
- 1 December 2004
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1028 (1) , 289-293
Expression of IAPs and Alternative Splice Variants in Hepatocellular Carcinoma Tissues and Cells
Abstract: IAPs (inhibitors of apoptosis proteins) might have a major role in the apoptotic resistance that marks many cancers. The studies on IAPs in human HCC have focused on survivin or XIAP, indicating that their new or increased expression in this tumor is associated with a more unfavorable prognosis. The present results corroborate these findings, emphasizing the role that the coordinated expression of different IAPs and alternative splice variants might play in the adverse biology of hepatocellular carcinoma.
- 1 December 2004
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1028 (1) , 289-293
Expression of IAPs and Alternative Splice Variants in Hepatocellular Carcinoma Tissues and Cells
Abstract: IAPs (inhibitors of apoptosis proteins) might have a major role in the apoptotic resistance that marks many cancers. The studies on IAPs in human HCC have focused on survivin or XIAP, indicating that their new or increased expression in this tumor is associated with a more unfavorable prognosis. The present results corroborate these findings, emphasizing the role that the coordinated expression of different IAPs and alternative splice variants might play in the adverse biology of hepatocellular carcinoma.